Walleye Capital
AUPH icon

Walleye Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Walleye Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$455K Sell
30,700
-45,300
-60% -$662K ﹤0.01% 2742
2025
Q4 		$1.21M Buy
76,000
+50,100
+193% +$710K ﹤0.01% 2282
2025
Q3 		$286K Buy
25,900
+14,600
+129% +$159K ﹤0.01% 3048
2025
Q2 		$95.7K Buy
11,300
+2,500
+28% +$20K ﹤0.01% 3791
2025
Q1 		$70.8K Sell
8,800
-21,200
-71% -$172K ﹤0.01% 3746
2024
Q4 		$269K Buy
30,000
+2,500
+9% +$20.4K ﹤0.01% 3521
2024
Q3 		$202K Buy
+27,500
New +$171K ﹤0.01% 4002
2024
Q2 		– Sell
-4,100
Closed -$20.5K – 5573
2024
Q1 		$20.5K Buy
+4,100
New +$27.8K ﹤0.01% 4919
2023
Q1 		– Sell
-1,000
Closed -$4.32K – 3928
2022
Q4 		$4.32K Sell
1,000
-1,000
-50% -$5.8K ﹤0.01% 2878
2022
Q3 		$15K Buy
+2,000
New +$17.3K ﹤0.01% 2764

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return